Insulin growth factor-1 decreases muscle atrophy following denervation
โ Scribed by Charles S. Day; Boonsin Buranapanitkit; Felix A. Riano; Matthew M. Tomaino; George Somogyi; Dean G. Sotereanos; Ryosuke Kuroda; Johnny Huard
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 633 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0738-1085
No coin nor oath required. For personal study only.
โฆ Synopsis
Despite modern microsurgical techniques for nerve repair, functional outcome following proximal injury is often unsatisfactory because irreversible muscle atrophy may develop before reinnervation occurs. Because insulin growth factor-1 (IGF-1) has been shown to improve muscle regeneration after injury, and may have a role in muscle preservation following denervation, the purpose of this investigation was to evaluate the histological, immunohistochemical, and electrophysiological differences between normal, denervated, and IGF-1-injected denervated muscle over an 8-week period. Denervated mice gastrocnemius muscles demonstrated a decrease in muscle weight, a decrease in myofiber diameter, an absence of muscle regeneration, an early increase in the number of neuromuscular junctions (NMJs), and a decrease in fast-twitch and maximum tetanic strength as compared to normal muscle up to 8 weeks following denervation. IGF-1-injected denervated muscle, on the other hand, sustained muscle diameter and muscle weight, maintained a smaller number of NMJs, and relatively sustained fast-twitch and maximum tetanic strength as compared to normal muscle over 8 weeks. These data suggest that IGF-1 may help prevent muscle atrophy and secondary functional compromise after denervation.
๐ SIMILAR VOLUMES
Neonatal sciatic nerve axotomy causes motoneuron death and muscle denervation atrophy. The aim of the present study was to determine whether insulin-like growth factor-I (IGF-I) administration promotes muscle reinnervation and counteracts motor neuron loss after such an injury. Six weeks after sciat